Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women

Autor: Ulrich Winkler, Johannes Jakobsen Sidelmann, Andrea H. Krug, Jørgen Jespersen, Jørgen Gram, Cornelis Kluft
Rok vydání: 2016
Předmět:
0301 basic medicine
alpha-2-Antiplasmin/metabolism
Time Factors
Protein Conformation
medicine.medical_treatment
Clot lysis
Peptide Hydrolases/blood
030204 cardiovascular system & hematology
Fibrinogen
Plasminogen/metabolism
Tissue plasminogen activator
0302 clinical medicine
Fibrinolysin
education.field_of_study
biology
Fibrinolysis
Thrombin
Hematology
Fibrinolysis/drug effects
Fibrin/chemistry
Europe
Contraceptives
Oral
Hormonal/administration & dosage

Coagulation
Female
Fibrin Fibrinogen Degradation Products/metabolism
medicine.drug
Adult
medicine.medical_specialty
Adolescent
Drug Compounding
Population
Antithrombin III
Fibrin
Drug Administration Schedule
Contraceptives
Oral
Hormonal

Fibrin structure
Fibrin Fibrinogen Degradation Products
03 medical and health sciences
Fibrinolysin/metabolism
Young Adult
Internal medicine
medicine
Humans
education
Blood Coagulation
alpha-2-Antiplasmin
Thrombin/metabolism
Oral contraceptives
business.industry
Plasminogen
030104 developmental biology
Endocrinology
Blood Coagulation/drug effects
Immunology
biology.protein
business
Biomarkers/blood
Biomarkers
Peptide Hydrolases
Zdroj: Sidelmann, J J, Kluft, C, Krug, A H, Winkler, U, Jespersen, J & Gram, J B 2017, ' Fibrin clot structure-pro-fibrinolytic effect of oral contraceptives in apparently healthy women ', Thrombosis and Haemostasis, vol. 117, no. 4, pp. 700-705 . https://doi.org/10.1160/TH16-10-0748
ISSN: 2567-689X
DOI: 10.1160/TH16-10-0748
Popis: SummaryFibrin metabolism is influenced by many factors. The velocity of fibrin formation, genetic polymorphisms, fibrinolytic features and the structure of the fibrin clot are determinants of fibrin turnover. Oral contraceptives (OCs) have significant impact on the haemostatic system, by increasing the concentration of coagulation factors, plasminogen and tissue plasminogen activator activity, and decreasing the concentration of haemostatic inhibitors. The present study addresses the influence of OCs on fibrin structure and fibrin metabolism. The study included 70 women treated with seven different OC-formulations. Blood was collected at baseline and after six months of OCs. The plasma concentration of fibrinogen, thrombin-antithrombin complex (TAT), plasminogen, plasmin-antiplasmin complex (PAP), D-Dimer and thrombin generation measures were determined. Fibrin structure measures and fibrin clot lysis not affected by the plasma concentration of plasminogen activators and inhibitors were determined. OCs increased the concentration of fibrinogen, TAT, plasminogen, PAP and D-dimer significantly and affected measures of thrombin generation (p
Databáze: OpenAIRE